Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2000
08/03/2000CA2361246A1 Identification of specific differentially expressed antigens
08/03/2000CA2360752A1 Method for preparing membrane vesicles
08/03/2000CA2360672A1 Methods for preventing graft rejection and ischemia-reperfusion injury
08/03/2000CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000CA2360146A1 Methods for inhibiting brain tumor growth by using selected integrin antagonists
08/03/2000CA2360082A1 Peptides and proteins for desensitizing subjects allergic to bee venom and compositions containing same
08/03/2000CA2360019A1 Anti-ccr1 antibodies and methods of use therefor
08/03/2000CA2359994A1 Production of tetravalent antibodies
08/03/2000CA2359210A1 Compartmentalization of recombinant polypeptides in host cells
08/03/2000CA2357525A1 Treating cancers associated with overexpression of her-2/neu
08/03/2000CA2296936A1 Novel core 2 beta-1,6-n-acetylglycosaminyltransferase
08/02/2000EP1024189A1 Novel antigenic class of avian reoviruses
08/02/2000EP1023906A1 Potentiator for antibody against lymphoid tumor
08/02/2000EP1023905A2 Pharmaceutical composition containing S-nitroso-immunoglobulins and use thereof
08/02/2000EP1023904A2 Adjuvants for use in vaccines
08/02/2000EP1023903A1 Use of life attenuated bacteria for the manufacture of a submucosal vaccine
08/02/2000EP1023900A2 Pharmaceutical composition containing S-nitroso-lipoproteins and use thereof
08/02/2000EP1023605A1 Methods and compositions for detecting hepatitis e virus
08/02/2000EP1023445A1 Cadherin derived growth factor and the application thereof
08/02/2000EP1023444A1 Cell division regulators
08/02/2000EP1023443A1 Mammoglobin homolog
08/02/2000EP1023441A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function
08/02/2000EP1023435A2 Novel lactic acid bacteria species
08/02/2000EP1023324A1 Trivalent thrombin inhibitor
08/02/2000EP1023323A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
08/02/2000EP1023322A1 Novel npy family member
08/02/2000EP1023320A1 PEPTIDES DERIVED FROM THE env GENE OF THE FELINE IMMUNODEFICIENCY VIRUS AND THEIR APPLICATIONS
08/02/2000EP1023319A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
08/02/2000EP1023311A1 Novel bacterial polypeptides and polynucleotides
08/02/2000EP1023083A1 Veterinary vaccines
08/02/2000EP1023082A1 Tumour vaccine
08/02/2000EP1023080A1 Ligand binding site of rage and uses thereof
08/02/2000EP1023054A1 Biphasic lipid vesicle composition for transdermal administration of an immunogen
08/02/2000EP1022958A1 Increasing the digestibility of food proteins by thioredoxin reduction
08/02/2000EP1022951A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
08/02/2000EP1022948A1 Induction of immune response to antigens expressed by recombinant adeno-associated virus
08/02/2000EP0682528B1 A pharmaceutical preparation for topical administration of antigens and/or vaccines to mammals via a mucosal membrane
08/02/2000EP0630407B1 Anti-viral fusion peptides
08/02/2000EP0554383B1 Blood coagulation protein antagonists and uses therefor
08/02/2000CN1261916A Enterococcus faecalis polynucleotides and polypeptides
08/02/2000CN1261896A Surface antigens and proteins useful in compositions for diagnosis and prevention of lyme disease
08/02/2000CN1261807A Improved method for transferring nucleic acid into the striped muscle and combination therefor
08/02/2000CN1261541A Anti-tumor biological product and preparing method
08/02/2000CN1055123C Protein structure of plant torin gelonin
08/02/2000CN1055093C Glucosamine disaccharides, its preparation and use, and pharmaceutical composition comprising same
08/02/2000CN1055024C Actinobacillus pleuropneumoniae subunit vaccine
08/02/2000CA2297507A1 Synthetic gene of bovine viral diarrhoea virus
08/01/2000US6096879 Nucleotide sequence coding microorganismal protein; for the diagnosis of the presence of viral particles in serum
08/01/2000US6096873 Mitogen polypeptide; for the treatment of nervous system and muscular disorders; anticarcinogenic agents
08/01/2000US6096872 Viral clearance process
08/01/2000US6096871 Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
08/01/2000US6096869 Treatment of papillomavirus-associated lesions
08/01/2000US6096728 Composition and method for treating inflammatory diseases
08/01/2000US6096706 Growth-promoting proteins and peptides for kidney epithelial cells
08/01/2000US6096541 Hepatocyte cell culture which replicates hepatitis c virus; for screening viricides
08/01/2000US6096538 Retroviral vectors
08/01/2000US6096535 Feline infectious peritonitis vaccine
08/01/2000US6096527 Nucleic acids encoding protein tryosine kinases
08/01/2000US6096521 Adhesin from Helicobacter pylori
08/01/2000US6096520 Brain glycogen phosphorylase cancer antigen
08/01/2000US6096519 Chlamydia trachomatis serotype D proteins
08/01/2000US6096518 DNA encoding SPO/REL polypeptides of streptococcus
08/01/2000US6096517 Human kidney sodium bicarbonate transporter (HNBC1A) polynucleotides
08/01/2000US6096516 cDNAs encoding murine antibody against human plasma apolipoprotein B-100
08/01/2000US6096513 Amino acid sequences; for screening agonists and antagonists; for analgesics
08/01/2000US6096323 Vaccine against papillomatous digital dermatitis (PDD)
08/01/2000US6096322 Pathogenicity and protective attributes of major clones of Escherichia coli recovered from chickens during processing
08/01/2000US6096321 ClpG subunit of CS31A protein capsule containing heterologous peptides
08/01/2000US6096320 Vaccines with chimeric protein comprising gamma-interferon and leukotoxin derived from pasteurella haemolytica
08/01/2000US6096319 Peptides with amino acid sequences
08/01/2000US6096318 Antigenically modified HCG polypeptides
08/01/2000US6096315 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
08/01/2000US6096314 Peptides and pharmaceutical compositions comprising them
08/01/2000US6096313 Immunology using peptides of amino acid sequences
08/01/2000US6096308 Human protein kinase and kinase inhibitors
08/01/2000CA2201601C Chimeric papillomavirus-like particles
08/01/2000CA2127091C Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines
08/01/2000CA2006322C Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
08/01/2000CA1341066C Small peptides which inhibit binding to t-4 receptors and act as immunogens
07/2000
07/29/2000CA2291962A1 Glucose regulated gene
07/29/2000CA2290078A1 Erysipelothrix rhusiopathiae antigens and vaccine compositions
07/29/2000CA2258973A1 Glucose regulated gene
07/27/2000WO2000043790A2 Compositions and methods for the diagnosis and treatment of tumor
07/27/2000WO2000043527A1 Varicella-zoster virus vaccines
07/27/2000WO2000043525A2 Metalloproteinase-disintegrin family members: svph dnas and polypeptides
07/27/2000WO2000043524A1 Polypeptides derived from jnk3
07/27/2000WO2000043519A2 Neisseria meningitidis polypeptides
07/27/2000WO2000043518A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
07/27/2000WO2000043517A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof
07/27/2000WO2000043515A2 Methods of monitoring hiv drug resistance
07/27/2000WO2000043511A1 Polypeptide
07/27/2000WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery
07/27/2000WO2000043039A1 Vaccine-mediated treatment of neurological disorders
07/27/2000WO2000043037A2 Hiv-encoded chemoattractant
07/27/2000WO2000043032A2 Baff, inhibitors thereof and their use in the modulation of b-cell response
07/27/2000WO2000043031A1 Tumor necrosis factor antagonists and their use in endometriosis
07/27/2000WO2000043030A1 Method of suppressing ongoing acute allograff rejection
07/27/2000WO2000043020A1 Egg anti-inflammatory composition and method of treating and preventing inflammation
07/27/2000WO2000043019A2 Egg anti-inflammatory composition and method of treating and preventing inflammation
07/27/2000WO2000042994A2 Inhibition of bacterial dissemination
1 ... 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 ... 1823